Search
for
Sort by
Research 631–660 of 699
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Decay of Skin-Specific Gene Modules in Pangolins
- Melatonin Promotes the Development of Secondary Hair Follicles in Adult Cashmere Goats by Activating the Keap1-Nrf2 Signaling Pathway and Inhibiting the Inflammatory Transcription Factors NFκB and AP-1
- Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
- Stepwise acquisition of unique epigenetic signatures during differentiation of tissue Treg cells
- Diseases of the Canine Prostate Gland
- ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review)
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Vitiligo—Current Treatment Options and Future Perspectives
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- The Wound Healing: A Mystery Still to Be Solved—What Is the Future?
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- ZNF750 safeguards upper hair follicle homeostasis to prevent inflammatory skin disease
- Hair Follicles as Micro-Organs: MicroRNA-Mediated Control of Growth, Cycling, and Fiber Traits
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
- Transcriptomic Analysis Provides Molecular Insights into Skin Development in Dezhou Donkey Foals
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Tacrolimus ointment: summarizing two decades of experience in off-label use. Use in rosacea, seborrheic dermatitis, papulosquamous dermatoses, lupus erythematosus, eczematous dermatoses, alopecia, and other diseases
- Hypoxic Preconditioned Nanofat at 1% O2 for 24 h Loses Its Regenerative In Vivo Vascularization Capacity
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation